Monday, June 29, 2026

HomeHealth NewsUsing metformin within 3 months of infection may reduce long COVID risk

Using metformin within 3 months of infection may reduce long COVID risk

- Advertisement -

Metformin pills move through a sorting machine at a Laurus Labs Ltd. pharmaceutical plant in Visakhapatnam, Andhra Pradesh, India, on Wednesday, Nov. 15, 2017. Image credit Bloomberg/Getty Images
  • Long COVID or post-COVID-19 condition is the long-term symptoms that can develop after experiencing COVID-19.
  • One study found that starting metformin within three months of SARS-CoV-2 infection diagnosis may decrease the risk of long COVID in people who have obesity or overweight.
  • Metformin is a…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed